Lista de obras -

A new biologic prognostic model based on immunohistochemistry predicts survival in patients with diffuse large B-cell lymphoma

artículo científico publicado en 2012

A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy

artículo científico publicado en 2009

Accurate classification of diffuse large B-cell lymphoma into germinal center and activated B-cell subtypes using a nuclease protection assay on formalin-fixed, paraffin-embedded tissues

artículo científico publicado en 2011

Activation of the STAT3 signaling pathway is associated with poor survival in diffuse large B-cell lymphoma treated with R-CHOP

artículo científico publicado en 2013

Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets

artículo científico publicado en 2017

BCL2 antibodies targeted at different epitopes detect varying levels of protein expression and correlate with frequent gene amplification in diffuse large B-cell lymphoma

artículo científico publicado en 2014

BCL2 predicts survival in germinal center B-cell-like diffuse large B-cell lymphoma treated with CHOP-like therapy and rituximab

artículo científico publicado en 2011

BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma

artículo científico publicado en 2004

Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics

artículo científico publicado en 2012

Chromosomal alterations detected by comparative genomic hybridization in subgroups of gene expression-defined Burkitt's lymphoma

article

Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma

artículo científico publicado en 2010

Colorimetric in situ hybridization identifies MYC gene signal clusters correlating with increased copy number, mRNA, and protein in diffuse large B-cell lymphoma

artículo científico publicado en 2013

Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone

artículo científico publicado en 2012

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

artículo científico publicado en 2004

Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling

artículo científico publicado en 2005

Decreased major histocompatibility complex class II expression in diffuse large B-cell lymphoma does not correlate with CpG methylation of class II transactivator promoters III and IV.

artículo científico publicado en 2009

Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue

artículo científico publicado en 2014

Diffuse large B-cell lymphoma cell-of-origin classification using the Lymph2Cx assay in the context of BCL2 and MYC expression status

artículo científico publicado en 2015

Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction

artículo científico publicado en 2005

Essential role of the linear ubiquitin chain assembly complex in lymphoma revealed by rare germline polymorphisms

artículo científico publicado en 2014

Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations

artículo científico publicado en 2009

Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOP.

artículo científico publicado en 2008

Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma

artículo científico publicado en 2014

Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma

scientific article published on 19 February 2019

Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma

artículo científico publicado en 2013

Genome-wide miRNA profiling of mantle cell lymphoma reveals a distinct subgroup with poor prognosis

artículo científico publicado en 2012

Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma

artículo científico publicado en 2014

High microvessel density determines a poor outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus chemotherapy.

artículo científico publicado en 2011

Identification of Primary Mediastinal Large B-cell Lymphoma at Nonmediastinal Sites by Gene Expression Profiling

artículo científico publicado en 2015

Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab

artículo científico publicado en 2010

Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Mol

artículo científico publicado en 2004

Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletions.

artículo científico publicado en 2005

Loss of signalling via Gα13 in germinal centre B-cell-derived lymphoma

artículo científico publicado en 2014

MicroRNA profiles of t(14;18)-negative follicular lymphoma support a late germinal center B-cell phenotype

artículo científico publicado en 2011

Molecular diagnosis of Burkitt's lymphoma

artículo científico publicado en 2006

Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma

artículo científico publicado en 2003

Mutation and genomic deletion status of ataxia telangiectasia mutated (ATM) and p53 confer specific gene expression profiles in mantle cell lymphoma

artículo científico publicado en 2006

New Molecular Assay for the Proliferation Signature in Mantle Cell Lymphoma Applicable to Formalin-Fixed Paraffin-Embedded Biopsies

artículo científico

Oncogenically active MYD88 mutations in human lymphoma

artículo científico publicado en 2011

Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling

artículo científico publicado en 2010

Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune Cells

article

SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype.

artículo científico publicado en 2009

Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study.

artículo científico publicado en 2008

The Stromal Cell Marker SPARC Predicts for Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab

article

Transformation of follicular lymphoma to diffuse large B-cell lymphoma proceeds by distinct oncogenic mechanisms

artículo científico publicado en 2007

Tumor-associated macrophages and survival in classic Hodgkin's lymphoma

artículo científico publicado en 2010

Validation of tissue microarray immunohistochemistry staining and interpretation in diffuse large B-cell lymphoma

artículo científico publicado en 2005

Lista de obras de

A new biologic prognostic model based on immunohistochemistry predicts survival in patients with diffuse large B-cell lymphoma

A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy

Accurate classification of diffuse large B-cell lymphoma into germinal center and activated B-cell subtypes using a nuclease protection assay on formalin-fixed, paraffin-embedded tissues

Activation of the STAT3 signaling pathway is associated with poor survival in diffuse large B-cell lymphoma treated with R-CHOP

Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets

BCL2 antibodies targeted at different epitopes detect varying levels of protein expression and correlate with frequent gene amplification in diffuse large B-cell lymphoma

BCL2 predicts survival in germinal center B-cell-like diffuse large B-cell lymphoma treated with CHOP-like therapy and rituximab

BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma

Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics

Chromosomal alterations detected by comparative genomic hybridization in subgroups of gene expression-defined Burkitt's lymphoma

Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma

Colorimetric in situ hybridization identifies MYC gene signal clusters correlating with increased copy number, mRNA, and protein in diffuse large B-cell lymphoma

Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling

Decreased major histocompatibility complex class II expression in diffuse large B-cell lymphoma does not correlate with CpG methylation of class II transactivator promoters III and IV.

Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue

Diffuse large B-cell lymphoma cell-of-origin classification using the Lymph2Cx assay in the context of BCL2 and MYC expression status

Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction

Essential role of the linear ubiquitin chain assembly complex in lymphoma revealed by rare germline polymorphisms

Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations

Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOP.

Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma

Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma

Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma

Genome-wide miRNA profiling of mantle cell lymphoma reveals a distinct subgroup with poor prognosis

Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma

High microvessel density determines a poor outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus chemotherapy.

Identification of Primary Mediastinal Large B-cell Lymphoma at Nonmediastinal Sites by Gene Expression Profiling

Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab

Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Mol

Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletions.

Loss of signalling via Gα13 in germinal centre B-cell-derived lymphoma

MicroRNA profiles of t(14;18)-negative follicular lymphoma support a late germinal center B-cell phenotype

Molecular diagnosis of Burkitt's lymphoma

Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma

Mutation and genomic deletion status of ataxia telangiectasia mutated (ATM) and p53 confer specific gene expression profiles in mantle cell lymphoma

New Molecular Assay for the Proliferation Signature in Mantle Cell Lymphoma Applicable to Formalin-Fixed Paraffin-Embedded Biopsies

Oncogenically active MYD88 mutations in human lymphoma

Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling

Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune Cells

SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype.

Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study.

The Stromal Cell Marker SPARC Predicts for Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab

Transformation of follicular lymphoma to diffuse large B-cell lymphoma proceeds by distinct oncogenic mechanisms

Tumor-associated macrophages and survival in classic Hodgkin's lymphoma

Validation of tissue microarray immunohistochemistry staining and interpretation in diffuse large B-cell lymphoma